Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase
Huang, Daniel Q, Tran, Andrew, Yeh, Ming-Lun, Yasuda, Satoshi, Tsai, Pei-Chien, Huang, Chung-Feng, Dai, Chia Yen, Ogawa, Eiichi, Ishigami, Masatoshi, Ito, Takanori, Kozuka, Ritsuzo, Enomoto, Masaru, Suzuki, Takanori, Yoshimaru, Yoko, Preda, Carmen M, Marin, Raluca I, Sandra, Irina, Tran, Sally, Quek, Sabrina X Z, Khine, Htet Htet Toe Wai, Itokawa, Norio, Atsukawa, Masanori, Uojima, Haruki, Watanabe, Tsunamasa, Takahashi, Hirokazu, Inoue, Kaori, Maeda, Mayumi, Hoang, Joseph K, Trinh, Lindsey, Barnett, Scott, Cheung, Ramsey, Lim, Seng Gee, Trinh, Huy N, Chuang, Wan-Long, Tanaka, Yasuhito, Toyoda, Hidenori, Yu, Ming-Lung, Nguyen, Mindie H
Published in Hepatology (Baltimore, Md.) (01.11.2023)
Published in Hepatology (Baltimore, Md.) (01.11.2023)
Get full text
Journal Article